Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia
- 1 February 2003
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (4) , 418-424
- https://doi.org/10.1016/s0002-9149(02)03236-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemiaEuropean Heart Journal, 2003
- Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemiaThe American Journal of Cardiology, 2002
- Ezetimibe co-administered with atorvastatin in 628 patients with primary hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Effect of ezetimibe on serum concentrations of lipid-soluble vitaminsAtherosclerosis Supplements, 2001
- Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663British Journal of Pharmacology, 2000
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993